Matches in DBpedia 2016-04 for { ?s ?p "Raymond J. St. Leger (born 1957, in London, England) is an American mycologist, entomologist and molecular biologist who currently holds the rank of Distinguished University Professor in the Department of Entomology at the University of Maryland, College Park. He was the recipient of the Universities 2009 Distinguished Scholar Teacher Award and in 2013 he joined Dr. Tammatha O’Brien in teaching a massive open online Coursera course called Genes and the Human Condition. St. Leger has published almost 150 scientific papers and book chapters on fungal pathogens of plants, animals and insects, and on the reactions of hosts to infection. St. Leger’s dominating research interest has been directed toward understanding entomopathogenic fungus (fungi that act as parasites of insects), and using them as models for understanding how pathogens in general respond to changing environments, initiate host invasion, colonize tissues, and counter host immune responses. These investigations have also addressed the mechanisms by which new pathogens emerge with different host ranges. St. Leger is leading a project to sequence multiple pathogens in collaboration with The Genome Institute (Washington University School of Medicine) and the Shanghai Institutes for Biological Sciences. Their intent is to create highly accurate genome sequences in order to identify small genetic differences that can lead to the evolution of new pathogens. Other interests include fungal and insect behavior and evolution, molecular biology of fungi, pest control and mutualistic associations between microbes and plants that can be exploited to benefit agriculture.St. Leger's most controversial work has involved altering insect pathogens so that they carry genes encoding spider and scorpion toxins. These engineered pathogens have the potential to control insect borne diseases such as malaria, and insect pests of agricultural importance. Although this avenue of work has been praised in many quarters, it was also suggested that it may be so emotive outside of science as to foster acute anxiety in the wider world (Bernard Dixon, Editorial comment in Microbe, Vol. 3 page 216, 2008). Another approach, which has been less controversial, is to engineer the fungus to carry a gene for a human anti-malarial antibody so that the fungus targets the malarial parasite in the mosquito. The fungus does not kill mosquitoes until they are old, so natural selection would not act against infected mosquitoes (http://insects.about.com/b/2011/02/28/could-genetically-engineered-fungus-mean-the-end-of-malaria.htm).St. Leger received his Bachelor of Science in biology from Exeter University, in the United Kingdom in 1978, a Master of Science in entomology in 1980 from Birkbeck College London University, and a Doctor of Philosophy in 1985 in crop protection from the University of Bath, near Bath, England.St. Leger has been a consultant on biotechnology to many private and public concerns, including the USDA, the NSF, the US State Department and the Organization of American States. St. Leger has also served on many national and international policy making committees including the Bill Gates funded National Academies Committee to study technologies to benefit SubSaharan Africa and South Asia (2007). St. Leger gave the Founders lecture at the 2009 Society of Invertebrate Pathology Meeting."@en }
Showing triples 1 to 2 of
2
with 100 triples per page.
- Raymond_St._Leger abstract "Raymond J. St. Leger (born 1957, in London, England) is an American mycologist, entomologist and molecular biologist who currently holds the rank of Distinguished University Professor in the Department of Entomology at the University of Maryland, College Park. He was the recipient of the Universities 2009 Distinguished Scholar Teacher Award and in 2013 he joined Dr. Tammatha O’Brien in teaching a massive open online Coursera course called Genes and the Human Condition. St. Leger has published almost 150 scientific papers and book chapters on fungal pathogens of plants, animals and insects, and on the reactions of hosts to infection. St. Leger’s dominating research interest has been directed toward understanding entomopathogenic fungus (fungi that act as parasites of insects), and using them as models for understanding how pathogens in general respond to changing environments, initiate host invasion, colonize tissues, and counter host immune responses. These investigations have also addressed the mechanisms by which new pathogens emerge with different host ranges. St. Leger is leading a project to sequence multiple pathogens in collaboration with The Genome Institute (Washington University School of Medicine) and the Shanghai Institutes for Biological Sciences. Their intent is to create highly accurate genome sequences in order to identify small genetic differences that can lead to the evolution of new pathogens. Other interests include fungal and insect behavior and evolution, molecular biology of fungi, pest control and mutualistic associations between microbes and plants that can be exploited to benefit agriculture.St. Leger's most controversial work has involved altering insect pathogens so that they carry genes encoding spider and scorpion toxins. These engineered pathogens have the potential to control insect borne diseases such as malaria, and insect pests of agricultural importance. Although this avenue of work has been praised in many quarters, it was also suggested that it may be so emotive outside of science as to foster acute anxiety in the wider world (Bernard Dixon, Editorial comment in Microbe, Vol. 3 page 216, 2008). Another approach, which has been less controversial, is to engineer the fungus to carry a gene for a human anti-malarial antibody so that the fungus targets the malarial parasite in the mosquito. The fungus does not kill mosquitoes until they are old, so natural selection would not act against infected mosquitoes (http://insects.about.com/b/2011/02/28/could-genetically-engineered-fungus-mean-the-end-of-malaria.htm).St. Leger received his Bachelor of Science in biology from Exeter University, in the United Kingdom in 1978, a Master of Science in entomology in 1980 from Birkbeck College London University, and a Doctor of Philosophy in 1985 in crop protection from the University of Bath, near Bath, England.St. Leger has been a consultant on biotechnology to many private and public concerns, including the USDA, the NSF, the US State Department and the Organization of American States. St. Leger has also served on many national and international policy making committees including the Bill Gates funded National Academies Committee to study technologies to benefit SubSaharan Africa and South Asia (2007). St. Leger gave the Founders lecture at the 2009 Society of Invertebrate Pathology Meeting.".
- Q7299157 abstract "Raymond J. St. Leger (born 1957, in London, England) is an American mycologist, entomologist and molecular biologist who currently holds the rank of Distinguished University Professor in the Department of Entomology at the University of Maryland, College Park. He was the recipient of the Universities 2009 Distinguished Scholar Teacher Award and in 2013 he joined Dr. Tammatha O’Brien in teaching a massive open online Coursera course called Genes and the Human Condition. St. Leger has published almost 150 scientific papers and book chapters on fungal pathogens of plants, animals and insects, and on the reactions of hosts to infection. St. Leger’s dominating research interest has been directed toward understanding entomopathogenic fungus (fungi that act as parasites of insects), and using them as models for understanding how pathogens in general respond to changing environments, initiate host invasion, colonize tissues, and counter host immune responses. These investigations have also addressed the mechanisms by which new pathogens emerge with different host ranges. St. Leger is leading a project to sequence multiple pathogens in collaboration with The Genome Institute (Washington University School of Medicine) and the Shanghai Institutes for Biological Sciences. Their intent is to create highly accurate genome sequences in order to identify small genetic differences that can lead to the evolution of new pathogens. Other interests include fungal and insect behavior and evolution, molecular biology of fungi, pest control and mutualistic associations between microbes and plants that can be exploited to benefit agriculture.St. Leger's most controversial work has involved altering insect pathogens so that they carry genes encoding spider and scorpion toxins. These engineered pathogens have the potential to control insect borne diseases such as malaria, and insect pests of agricultural importance. Although this avenue of work has been praised in many quarters, it was also suggested that it may be so emotive outside of science as to foster acute anxiety in the wider world (Bernard Dixon, Editorial comment in Microbe, Vol. 3 page 216, 2008). Another approach, which has been less controversial, is to engineer the fungus to carry a gene for a human anti-malarial antibody so that the fungus targets the malarial parasite in the mosquito. The fungus does not kill mosquitoes until they are old, so natural selection would not act against infected mosquitoes (http://insects.about.com/b/2011/02/28/could-genetically-engineered-fungus-mean-the-end-of-malaria.htm).St. Leger received his Bachelor of Science in biology from Exeter University, in the United Kingdom in 1978, a Master of Science in entomology in 1980 from Birkbeck College London University, and a Doctor of Philosophy in 1985 in crop protection from the University of Bath, near Bath, England.St. Leger has been a consultant on biotechnology to many private and public concerns, including the USDA, the NSF, the US State Department and the Organization of American States. St. Leger has also served on many national and international policy making committees including the Bill Gates funded National Academies Committee to study technologies to benefit SubSaharan Africa and South Asia (2007). St. Leger gave the Founders lecture at the 2009 Society of Invertebrate Pathology Meeting.".